Compare $CLYM vs $OLMA | Chartloom

Compare

$CLYM vs $OLMA

Climb Bio Inc · Olema Pharmaceuticals Inc

CLYM

Climb Bio Inc

OLMA

Olema Pharmaceuticals Inc

Compare $CLYM vs $OLMA

Comparing Climb Bio Inc and Olema Pharmaceuticals Inc

CLYMClimb Bio Inc

OLMAOlema Pharmaceuticals Inc

CLYMClimb Bio Inc

Market cap

$630M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

193.3%

52W performance

511.1%

FCF yield

-8.4%

OLMAOlema Pharmaceuticals Inc

Market cap

$683M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-27.1%

FCF yield

-24.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLYM

OLMA

Detailed metrics comparison

CLYM

Climb Bio Inc

OLMA

Olema Pharmaceuticals Inc

Market Cap

CLYM$630M

OLMA$683M

Enterprise Value

CLYM$586M

OLMA$637M

Price

CLYM$11.00

OLMA$7.82

P/E Ratio

CLYMN/A

OLMAN/A

P/S Ratio

CLYM0.00x

OLMA0.00x

EV/Sales

CLYM0.00x

OLMA0.00x

EV/EBITDA

CLYM0.00x

OLMA0.00x

P/B Ratio

CLYM2.62x

OLMA1.67x

P/FCF Ratio

CLYMN/A

OLMAN/A

EV/FCF

CLYM-11.04x

OLMA-3.86x

PEG Ratio

CLYMN/A

OLMAN/A

Forward P/E (NTM)

CLYMN/A

OLMAN/A

Forward P/S (NTM)

CLYMN/A

OLMAN/A

Revenue (TTM)

CLYM$0

OLMA$0

Revenue Growth (YoY)

CLYMN/A

OLMAN/A

Forward Rev Growth

CLYM27.3%

OLMA820.6%

Gross Margin (TTM)

CLYM0.0%

OLMA0.0%

Operating Margin (TTM)

CLYM0.0%

OLMA0.0%

EBITDA Margin (TTM)

CLYM0.0%

OLMA0.0%

Net Margin (TTM)

CLYM0.0%

OLMA0.0%

FCF Margin (TTM)

CLYMN/A

OLMAN/A

Net Income (TTM)

CLYM$-58M

OLMA$-205M

FCF (TTM)

CLYM$-53M

OLMA$-165M

EPS (TTM)

CLYM-$0.76

OLMA-$1.96

ROE (TTM)

CLYM-3179.0%

OLMA-4822.0%

ROA (TTM)

CLYM-3079.0%

OLMA-4300.0%

ROIC (TTM)

CLYM-3179.0%

OLMA-4788.0%

Cash

CLYM$44M

OLMA$49M

Debt

CLYM$0

OLMA$3M

Net Cash/Debt

CLYM$44M

OLMA$46M

Current Ratio (TTM)

CLYM31.45x

OLMA8.86x

Quick Ratio (TTM)

CLYM30.86x

OLMA8.75x

Debt/Equity (TTM)

CLYM0.00x

OLMA0.01x

Debt/Assets (TTM)

CLYM0.0%

OLMA0.0%

Interest Coverage (TTM)

CLYMN/A

OLMAN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

OLMA0.00x

Beta

CLYM-0.01

OLMA1.98

52W Performance

CLYM511.1%

OLMA-27.1%

YTD Performance

CLYM193.3%

OLMA-69.1%

% from 52W High

CLYM-40.0%

OLMA-78.4%

% from 52W Low

CLYM572.8%

OLMA17.6%

Asset Turnover (TTM)

CLYM0.00x

OLMA0.00x

FCF Yield (TTM)

CLYM-8.4%

OLMA-24.1%

Earnings Yield (TTM)

CLYM-9.1%

OLMA-29.9%

Dividend Yield (TTM)

CLYMN/A

OLMAN/A

Rule of 40

CLYM0.0

OLMA0.0

EV/GP/RG

CLYMN/A

OLMAN/A

Ticker research

View CLYM research View OLMA research

Metric	CLYM Climb Bio Inc	OLMA Olema Pharmaceuticals Inc
Market & Valuation
Market Cap	$630M	$683M
Enterprise Value	$586M	$637M
Price	$11.00	$7.82
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.62x	1.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-3.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	27.3%	820.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-205M
FCF (TTM)	$-53M	$-165M
EPS (TTM)	-$0.76	-$1.96
ROE (TTM)	-3179.0%	-4822.0%
ROA (TTM)	-3079.0%	-4300.0%
ROIC (TTM)	-3179.0%	-4788.0%
Financial Health
Cash	$44M	$49M
Debt	$0	$3M
Net Cash/Debt	$44M	$46M
Current Ratio (TTM)	31.45x	8.86x
Quick Ratio (TTM)	30.86x	8.75x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	1.98
52W Performance	511.1%	-27.1%
YTD Performance	193.3%	-69.1%
% from 52W High	-40.0%	-78.4%
% from 52W Low	572.8%	17.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-24.1%
Earnings Yield (TTM)	-9.1%	-29.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View OLMA research

Valuation

P/S Ratio

CLYM

0.00x

OLMA

0.00x

EV/FCF

CLYM

-11.04x

OLMA

-3.86x

Growth & revenue

Forward Revenue Growth

OLMA

820.6%

CLYM

27.3%

Profitability & performance

Gross Margin

CLYM

0.0%

OLMA

0.0%

ROE

CLYM

-3179.0%

OLMA

-4822.0%

FCF Yield %

CLYM

-8.4%

OLMA

-24.1%

52-Week Performance

CLYM

511.1%

OLMA

-27.1%

Detailed metrics comparison

CLYM

Climb Bio Inc

OLMA

Olema Pharmaceuticals Inc

Market Cap

CLYM$630M

OLMA$683M

Enterprise Value

CLYM$586M

OLMA$637M

Price

CLYM$11.00

OLMA$7.82

P/E Ratio

CLYMN/A

OLMAN/A

P/S Ratio

CLYM0.00x

OLMA0.00x

EV/Sales

CLYM0.00x

OLMA0.00x

EV/EBITDA

CLYM0.00x

OLMA0.00x

P/B Ratio

CLYM2.62x

OLMA1.67x

P/FCF Ratio

CLYMN/A

OLMAN/A

EV/FCF

CLYM-11.04x

OLMA-3.86x

PEG Ratio

CLYMN/A

OLMAN/A

Forward P/E (NTM)

CLYMN/A

OLMAN/A

Forward P/S (NTM)

CLYMN/A

OLMAN/A

Revenue (TTM)

CLYM$0

OLMA$0

Revenue Growth (YoY)

CLYMN/A

OLMAN/A

Forward Rev Growth

CLYM27.3%

OLMA820.6%

Gross Margin (TTM)

CLYM0.0%

OLMA0.0%

Operating Margin (TTM)

CLYM0.0%

OLMA0.0%

EBITDA Margin (TTM)

CLYM0.0%

OLMA0.0%

Net Margin (TTM)

CLYM0.0%

OLMA0.0%

FCF Margin (TTM)

CLYMN/A

OLMAN/A

Net Income (TTM)

CLYM$-58M

OLMA$-205M

FCF (TTM)

CLYM$-53M

OLMA$-165M

EPS (TTM)

CLYM-$0.76

OLMA-$1.96

ROE (TTM)

CLYM-3179.0%

OLMA-4822.0%

ROA (TTM)

CLYM-3079.0%

OLMA-4300.0%

ROIC (TTM)

CLYM-3179.0%

OLMA-4788.0%

Cash

CLYM$44M

OLMA$49M

Debt

CLYM$0

OLMA$3M

Net Cash/Debt

CLYM$44M

OLMA$46M

Current Ratio (TTM)

CLYM31.45x

OLMA8.86x

Quick Ratio (TTM)

CLYM30.86x

OLMA8.75x

Debt/Equity (TTM)

CLYM0.00x

OLMA0.01x

Debt/Assets (TTM)

CLYM0.0%

OLMA0.0%

Interest Coverage (TTM)

CLYMN/A

OLMAN/A

Net Debt/EBITDA (TTM)

CLYM0.00x

OLMA0.00x

Beta

CLYM-0.01

OLMA1.98

52W Performance

CLYM511.1%

OLMA-27.1%

YTD Performance

CLYM193.3%

OLMA-69.1%

% from 52W High

CLYM-40.0%

OLMA-78.4%

% from 52W Low

CLYM572.8%

OLMA17.6%

Asset Turnover (TTM)

CLYM0.00x

OLMA0.00x

FCF Yield (TTM)

CLYM-8.4%

OLMA-24.1%

Earnings Yield (TTM)

CLYM-9.1%

OLMA-29.9%

Dividend Yield (TTM)

CLYMN/A

OLMAN/A

Rule of 40

CLYM0.0

OLMA0.0

EV/GP/RG

CLYMN/A

OLMAN/A

Ticker research

View CLYM research View OLMA research

Metric	CLYM Climb Bio Inc	OLMA Olema Pharmaceuticals Inc
Market & Valuation
Market Cap	$630M	$683M
Enterprise Value	$586M	$637M
Price	$11.00	$7.82
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.62x	1.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.04x	-3.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	27.3%	820.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-58M	$-205M
FCF (TTM)	$-53M	$-165M
EPS (TTM)	-$0.76	-$1.96
ROE (TTM)	-3179.0%	-4822.0%
ROA (TTM)	-3079.0%	-4300.0%
ROIC (TTM)	-3179.0%	-4788.0%
Financial Health
Cash	$44M	$49M
Debt	$0	$3M
Net Cash/Debt	$44M	$46M
Current Ratio (TTM)	31.45x	8.86x
Quick Ratio (TTM)	30.86x	8.75x
Debt/Equity (TTM)	0.00x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.01	1.98
52W Performance	511.1%	-27.1%
YTD Performance	193.3%	-69.1%
% from 52W High	-40.0%	-78.4%
% from 52W Low	572.8%	17.6%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-8.4%	-24.1%
Earnings Yield (TTM)	-9.1%	-29.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CLYM research	View OLMA research